 Renormalization high cardiac output left ventricular size long-term recombinant human erythropoietin treatment anemic dialyzed uremic patients information effects correction uremic anemia cardiac function size normotensive patients months start i.v treatment recombinant human erythropoietin rHuEPO Pulsed-doppler echocardiographic determinations cardiac index CI M-Mode echocardiographic estimations indexed ventricular end diastolic diameter LVEDDi interventricular septum IVSi ventricular posterior wall LVPWi calculations left ventricular mass index LVMi occasion Mean SD hemoglobin Hb concentration rHuEPO g/dl third month constant Baseline CI healthy subjects third month value different controls pooled baseline third month data inverse relationship Hb CI Baseline LVEDDi IVSi LVPWi controls months therapy change decrease LVPWi months indices LVMi controls pooled baseline months data inverse relationship Hb LVMi treatment uremic patients rHuEPO able cardiac output correction anemia